Page 2 - ஃப்ல்யாஂட்ஸ் கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஃப்ல்யாஂட்ஸ் கண்டுபிடிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஃப்ல்யாஂட்ஸ் கண்டுபிடிப்பு Today - Breaking & Trending Today

Pulsify Medical closes second round Series A funding of EUR 5.4 million for wearable ultrasound heart monitor patch

Search jobs
04-May-2021
Pulsify Medical closes second round Series A funding of EUR 5.4 million for wearable ultrasound heart monitor patch
Pulsify Medical closes second round Series A funding of EUR 5.4 million for wearable ultrasound heart monitor patch
Pulsify Medical is developing wearable ultrasound patches to monitor vital human organs such as the heart. The company has announced the second closing of the Series A funding round with EUR 3.75 million in equity and EUR1.65 million as a non-dilutive grant.
Leuven, Belgium, 4 May 2021 - Pulsify Medical is a digital medical technology company developing wearable ultrasound patches which will monitor vital organs in real-time. The new and disruptive technology will address a serious unmet need for continuous cardiac monitoring in ICUs, hospitals, and homes across the world. ....

Region Flamande , Iwan Van Vijfeijken , Chris Japp , Steve Stoffels , Diane Lejeune , University Hospitals Leuven , Gemma Frisius Fund , Entrepreneurship Administration , Vp Technology Of Pulsify , Pulsify Medical , Flanders Innovation , Smart Patch , Business Manager , ஃப்ல்யாஂட்ஸ் கண்டுபிடிப்பு , புத்திசாலி இணைப்பு , வணிக மேலாளர் ,

Rejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products

Search jobs
02-Mar-2021
Rejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products
Rejuvenate Biomed Secures EUR 3.2 Million Series A Round to Advance Development of Healthy Aging Products
Heusden-Zolder, Belgium, 2 March 2021 – Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing prescription drugs for age-related diseases, announces it has completed a EUR 3.2 million Series A round. The funding is being used to advance the development of Rejuvenate’s lead candidate RJx-01 in both acute and chronic sarcopenia (disuse-induced and age-related muscle failure).
The financing included lead investor Vesalius Biocapital III and private non-disclosed investors, as well as existing investors. Additionally, Rejuvenate gratefully acknowledges the ongoing support of Flanders Innovation and Entrepreneurship (VLAIO) in non-dilutive funding. Concurrent with t ....

Eric Verdin , Bart Braeckman , Jean Yves Reginster , Ann Beli , Johan Auwerx , Andrea Maier , Marco Sandri , Rejuvenate Biomed Secures , Advance Development , Healthy Aging , Rejuvenate Biomed , Vesalius Biocapital , Flanders Innovation , Managing Partner , எரிக் வெர்டின் , ஆண்டு பெலி , ஆண்ட்ரியா மேயையர் , மார்கோ சாண்ட்ரி , புத்துயிர் பெறுங்கள் பயோமெட் , ஃப்ல்யாஂட்ஸ் கண்டுபிடிப்பு , நிர்வகித்தல் கூட்டாளர் ,